Atlas Trials

Bioequivalence Study of Carvedilol Tablets USP 12.5 mg Under Fasting Condition

Clinical trial NCT01577914 · COMPLETED

Trial details

NCT number
NCT01577914
Sponsor
IPCA Laboratories Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Fasting State
Start date
2011-07-01
Primary completion
2011-11-01
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.